Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
5
﹤0.01% 2299
2025
Q4
$0 Hold
5
﹤0.01% 2298
2025
Q3
$0 Hold
5
﹤0.01% 2318
2025
Q2
$0 Hold
5
﹤0.01% 2244
2025
Q1
$0 Hold
5
﹤0.01% 2258
2024
Q4
$0 Hold
5
﹤0.01% 2268
2024
Q3
$0 Sell
5
-4
-44% -$100 ﹤0.01% 2253
2024
Q2
$0 Hold
9
﹤0.01% 2266
2024
Q1
$0 Hold
9
﹤0.01% 2269
2023
Q4
$0 Sell
9
-1
-10% -$8 ﹤0.01% 2175
2023
Q3
$0 Sell
10
-2
-17% -$18 ﹤0.01% 2149
2023
Q2
$0 Buy
12
+6
+100% +$50 ﹤0.01% 2162
2023
Q1
$0 Hold
6
﹤0.01% 2061
2022
Q4
$0 Hold
6
﹤0.01% 2100
2022
Q3
$0 Sell
6
-2
-25% -$43 ﹤0.01% 2035
2022
Q2
$0 Buy
8
+1
+14% +$28 ﹤0.01% 1947
2022
Q1
$0 Sell
7
-2
-22% -$78 ﹤0.01% 2133
2021
Q4
$0 Buy
+9
New +$470 ﹤0.01% 2128

Other funds holding CDNA

Covestor's CDNA Position: Q1 2026 in Review

Covestor held its CareDx (CDNA) position steady in Q1 2026 at 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

Covestor first reported a position in CDNA in Q4 2021 and has held it in 18 quarters since. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Covestor held 5 shares of CareDx worth $0 as of Q1 2026.
  • Covestor left its CareDx share count unchanged in Q1 2026.
  • CareDx made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2299 holding.
  • Covestor first reported a position in CareDx in Q4 2021 and has held it in 18 quarters since.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.